Interleukin-7 (IL-7), acting via the IL-7 receptor (IL-7R), plays a significant role in tumor progression, is closely associated with a poor prognosis for patients with PC, and is associated with MMP-3 and MMP-7 expression [66,67]. Here, MMP7 is linked to pachyonychia congenita.